Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SUCLG2 |
| Upstream (Parents) |
|---|
| (<<) SLC35D1 → SUCLG2 |
| (<<) XYLB → SUCLG2 |
| (<<) SLC1A1 → SUCLG2 |
| (<<) PTP4A1 → SUCLG2 |
| (<<) SC5DL → SUCLG2 |
| (<<) ATP13A3 → SUCLG2 |
| (<<) CYP2J2 → SUCLG2 |
| Downstream (Children) |
|---|
| SUCLG2 → PAICS (>>) |
| SUCLG2 → BMP8A///BMP8B (>>) |
| SUCLG2 → WSCD1 (>>) |
| SUCLG2 → AMBRA1 (>>) |
| SUCLG2 → DOC2B (>>) |
| SUCLG2 → EWSR1 (>>) |
| SUCLG2 → VDAC1P8///LOC100288558///ADAT2///PEX3///FUCA2 (>>) |
| SUCLG2 → PRKACG (>>) |
| SUCLG2 → PRPF18 (>>) |
| SUCLG2 → DIAPH2 (>>) |
| SUCLG2 → ZXDB (>>) |
| SUCLG2 → PARP6 (>>) |
| SUCLG2 → PTENP1 (>>) |
| SUCLG2 → ZMYM6 (>>) |
| SUCLG2 → DNAJB5 (>>) |
| SUCLG2 → SC5DL (>>) |
| SUCLG2 → ATP13A3 (>>) |
| SUCLG2 → C11orf20 (>>) |
